T. Rowe Price Associates’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $983K | Buy |
|
|||||
|
2024
Q1 | $640K | Buy |
|
|||||
|
2023
Q4 | $411K | Buy |
|
|||||
|
2023
Q3 | $424K | Buy |
|
|||||
|
2023
Q2 | $795K | Buy |
|
|||||
|
2023
Q1 | $903K | Buy |
|
|||||
|
2022
Q4 | $992K | Buy |
|
|||||
|
2022
Q3 | $701K | Buy |
|
|||||
|
2022
Q2 | $485K | Buy |
|
|||||
|
2022
Q1 | $538K | Buy |
|
|||||
|
2021
Q4 | $526K | Buy |
|
|||||
|
2021
Q3 | $548K | Sell |
|
|||||
|
2021
Q2 | $479K | Buy |
|
|||||
|
2021
Q1 | $398K | Buy |
|
|||||
|
2020
Q4 | $444K | Buy |
|
|||||
|
2020
Q3 | $223K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.86M | Sell |
|
|||||
|
2019
Q4 | $3.89M | Sell |
|
|||||
|
2019
Q3 | $3.27M | Buy |
|